Literature DB >> 24649127

Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines.

Masahito Hagio1, Yoko Matsuda1, Taeko Suzuki1, Toshiyuki Ishiwata1.   

Abstract

Nestin, a class VI intermediate filament, is a neuronal stem/progenitor cell marker that is also expressed by various types of cancer, including pancreatic ductal adenocarcinoma (PDAC). We previously detected nestin expression in approximately 30% of PDAC cases, and found that nestin promotes the migration, invasion and metastasis of cells. Findings of recent studies have shown that epithelial mesenchymal transition (EMT) is important in the invasion and migration of cancer. In the present study, we investigated whether an altered nestin expression affected the expression levels of EMT markers in PDAC cells. Two human PDAC cell lines, PK-45H and KLM-1, in which nestin was suppressed and overexpressed, respectively, were used. The expression levels of the EMT-related molecules E-cadherin, Snail, Slug and Twist were analyzed using quantitative RT-PCR. Results showed that E-cadherin expression was decreased in nestin-overexpressed KLM-1 cells, and increased in nestin-suppressed PK-45H cells. Snail gene expression in the PDAC cells was altered concomitantly with the changes in nestin expression, while the Slug gene expression was significantly decreased in nestin-overexpressed KLM-1 cells. The Twist gene expression was below the detection limit in the two PDAC cell lines. The present findings indicated that nestin may be involved in the control of cancer behaviors in PDAC via the modulation of EMT-related molecules.

Entities:  

Keywords:  Slug; Snail; epithelial mesenchymal transition; nestin; pancreatic cancer

Year:  2012        PMID: 24649127      PMCID: PMC3956256          DOI: 10.3892/mco.2012.1

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  26 in total

Review 1.  The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it.

Authors:  Elizabeth D Hay
Journal:  Dev Dyn       Date:  2005-07       Impact factor: 3.780

Review 2.  An overview of epithelio-mesenchymal transformation.

Authors:  E D Hay
Journal:  Acta Anat (Basel)       Date:  1995

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

Review 4.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

5.  Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.

Authors:  Esmeralda Casas; Jihoon Kim; Andrés Bendesky; Lucila Ohno-Machado; Cecily J Wolfe; Jing Yang
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

6.  Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis.

Authors:  Yoko Matsuda; Zenya Naito; Kiyoko Kawahara; Nando Nakazawa; Murray Korc; Toshiyuki Ishiwata
Journal:  Cancer Biol Ther       Date:  2011-03-01       Impact factor: 4.742

Review 7.  The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Authors:  Molly A Taylor; Jenny G Parvani; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-15       Impact factor: 2.673

8.  Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-10-01

Review 9.  Epithelial-mesenchymal transitions in cancer progression.

Authors:  C Birchmeier; W Birchmeier; B Brand-Saberi
Journal:  Acta Anat (Basel)       Date:  1996

10.  Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma.

Authors:  David F Schaeffer; Kiran Assi; Katie Chan; Andrzej K Buczkowski; Stephen W Chung; Charles H Scudamore; Alan Weiss; Bill Salh; David A Owen
Journal:  Virchows Arch       Date:  2010-01-21       Impact factor: 4.064

View more
  5 in total

1.  Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance.

Authors:  Yan Zhang; Shan Zeng; Junli Ma; Ganlu Deng; Yanlin Qu; Cao Guo; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2016-07-13

2.  Nestin phosphorylation at threonines 315 and 1299 correlates with proliferation and metastasis of human pancreatic cancer.

Authors:  Yoko Matsuda; Toshiyuki Ishiwata; Hisashi Yoshimura; Kazuya Yamahatsu; Toshinari Minamoto; Tomio Arai
Journal:  Cancer Sci       Date:  2017-03-07       Impact factor: 6.716

Review 3.  Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease.

Authors:  James H Monkman; Erik W Thompson; Shivashankar H Nagaraj
Journal:  Cancers (Basel)       Date:  2019-11-07       Impact factor: 6.639

4.  Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway.

Authors:  Amber A Bokhari; Tabari M Baker; Batsukh Dorjbal; Sana Waheed; Christopher M Zahn; Chad A Hamilton; G Larry Maxwell; Viqar Syed
Journal:  Oncotarget       Date:  2016-10-25

5.  Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells.

Authors:  Hendrike Knaack; Lennart Lenk; Lisa-Marie Philipp; Lauritz Miarka; Sascha Rahn; Fabrice Viol; Charlotte Hauser; Jan-Hendrik Egberts; Jan-Paul Gundlach; Olga Will; Sanjay Tiwari; Wolfgang Mikulits; Udo Schumacher; Jan G Hengstler; Susanne Sebens
Journal:  Oncotarget       Date:  2018-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.